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Background. Monocytic human leukocyte antigen D related (mHLA-DR) is essential for antigen-presentation. Downregulation of
mHLA-DR emerged as a general biomarker of impaired immunity seen in patients with sepsis and pneumonia and after major
surgery. Influencing factors of mHLA-DR such as age, overweight, diabetes, smoking, and gender remain unclear. Methods. We
analyzed 20 patients after esophageal or pancreatic resection of a prospective, randomized, placebo-controlled, double-blind trial
(placebo group). mHLA-DR was determined from day of surgery (od) until postoperative day (pod) 5. Statistical analyses were
performed using multivariate generalized estimating equation analyses (GEE), nonparametric multivariate analysis of longitudinal
data, and univariate post hoc nonparametric Mann–Whitney tests. Results. In GEE, smoking and gender were confirmed as
significant influencing factors over time. Univariate analyses of mHLA-DR between smokers and nonsmokers showed lower
preoperative levels (𝑝 = 0.010) and a trend towards lower levels on pod5 (𝑝 = 0.056) in smokers. Lower mHLA-DR was seen
in men on pod3 (𝑝 = 0.038) and on pod5 (𝑝 = 0.026). Overweight patients (BMI > 25 kg/m2) had lower levels of mHLA-DR
on pod3 (𝑝 = 0.039) and pod4 (𝑝 = 0.047). Conclusion. Smoking is an important influencing factor on pre- and postoperative
immune function while postoperative immune function was influenced by gender and overweight. Clinical trial registered with
ISRCTN27114642.
1. Background
Antigen-presenting cells, that is, macrophages, dendritic
cells, and activated natural killer cells, express human leuko-
cyte antigen D related (HLA-DR) on their surface which is
crucial for immunologic competence [1, 2]. Immunogenic
peptides processed from ingested pathogens, for example,
bacterial proteins, are presented to T cells by HLA-DR.
Specific T cell antigen receptors recognize the HLA-DR-
antigen complex and subsequently activate the T cells [3].
Thus, the expression of HLA-DR reflects the functional state
of antigen-presenting cells.
Downregulation of HLA-DR expression on monocytes
(mHLA-DR) emerged as a general biomarker of impaired
immunity up to immune suppression which can predict out-
come [1, 4, 5]. In the state of reduced mHLA-DR expression,
the function of monocytes and T cell activation is severely
restricted [6] which results in up to five times higher risk
for infections and septic complications [7–9]. A reduced
mHLA-DR expression is associated with sepsis, pneumonia,
and surgical site infections [9–11] and furthermore seen in
patients after thoracic [12, 13] and major visceral surgery
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We and others used mHLA-DR expression to stratify
immune compromised patients after surgery [18, 19] and
during severe sepsis [20]. In both settings, mHLA-DR could
be increased through administration of GM-CSF restoring
immune function and improving outcome. However, reasons
for a decreased mHLA-DR expression frequently seen after
major surgery and during sepsis are not clearly understood.
Surgical stress and tissue damage resulting in an inflamma-
tory state are proposed to downregulate mHLA-DR through
cortisol and interleukin- (IL-) 10 [21, 22].
Various conditions can alter immune function generally
and particularly after surgery. Ageing [23, 24], obesity [25],
diabetes [26, 27], gender [1], and smoking [28, 29] have
an influence on the immune function, immune cells, and
cytokines. Smoking is suggested to trigger the development of
rheumatoid arthritis or multiple sclerosis due to interactions
between subtypes of HLA-DR alleles [30–32]. Furthermore,
smokers showed a decreased T cell function and a higher
rate of HLA-DR positive T cells, that is, a higher activation
[33]. Ono et al. found lower levels of mHLA-DR in men
compared to women on the first day after gastrectomy [1].
However, the influence of age, BMI, diabetes, and smoking
on pre- and postoperative mHLA-DR and immune function
is unclear. Thus, we analyzed mHLA-DR after major cancer
surgery regarding influencing factors such as age, overweight,
diabetes, smoking, gender, and surgical time.
2. Patients and Methods
2.1. Study Participants and Design. This retrospective sub-
group analysis refers to a previously published study of our
research group [18] which studied mHLA-DR in 20 out of 61
immune suppressed patients (mHLA-DR levels below 10,000
mAb per cell on pod1) from od until pod5 after elective
esophageal or pancreatic resections since these subgroup
patients were not treated with study medication (Figure 1).
All patients received guideline-based anesthesiological and
surgical treatment according to our standard operating pro-
cedures [34].
2.2. Measurement of mHLA-DR, Leukocytes, and C-Reactive
Protein. Blood samples were taken from od until pod5 and
intraoperative parameters (surgical time, blood glucose and
lactate levels, and blood pressure) were documented. mHLA-
DR, leukocytes, andC-reactive protein (CRP) weremeasured
in all patients from od until pod5 in cooperation with the
Institute of Medical Immunology and Berlin-Brandenburg
Center for Regenerative Therapies (BCRT), Charite´ - Uni-
versita¨tsmedizin Berlin, Berlin, Germany. mHLA-DR was
measured using a highly standardized quantitative assay
as described earlier [8]. Plasma levels of CRP were mea-
sured by an immunoturbidimetric assay (Roche Diagnostics,
Mannheim, Germany) whereas white blood cell analyses
were performed on a standard hematology analyzer (Sysmex
GmbH, Norderstedt, Germany).
2.3. Clinical Outcome Parameters. During the follow-up






















Figure 1: Consort diagram.
the standards of the CDC and ATS criteria for pneumonia
[35, 36], incidence of delirium using Delirium Detection
Score (DDS, [37]) with a DDS > 3, and hospital and ICU stay.
2.4. Statistical Analysis. Data were expressed according to
their scaling as arithmetic mean ± standard deviation (SD),
median [25%, 75%quartiles], or frequencies [%], respectively.
After exploratory data analysis, all tests were accomplished by
means of nonparametric exact statistical tests. Basic patient
characteristics were evaluated for group differences using
the Mann–Whitney tests for continuous variables and the
Fisher exact test for categorical variables. To detect influences
on mHLA-DR, we used multivariate generalized estimating
equation (GEE) over the six time points with mHLA-DR
as dependable variable and gender, smoking, diabetes, BMI,
age, and surgical time as independent variables. Significant
variables in GEE were taken as risk factors for mHLA-DR in
a multivariate nonparametric analysis of longitudinal data in
a two-factorial design and judged for corresponding impact.
This analysis tests for three hypotheses, namely, differences
in risk factors, systematic changes over time, and interactions
between differences and time. After such global testing,
univariate tests were further carried out as post hoc analyses
to detect specific differences with respect to those groups for
fixed times (exactMann–Whitney tests). A two-tailed𝑝 value
< 0.05 was considered statistically significant. All tests were
conducted in the area of exploratory data analysis.Therefore,
no adjustments for multiple testing have been made. The
calculations were performed with IBM© SPSS© Statistics,
Version 23 and SAS, Version 9.1, Copyright© by SAS Institute,
Inc., Cary, NC, USA.
3. Results
3.1. Study Population. All analyses were performed in 20
patients of the placebo group from od until pod5. mHLA-DR,
leukocytes, and CRP were measured in all patients.
3.2. Multivariate Analyses (GEE) of Influencing Factors on
mHLA-DR. Multivariate GEE was conducted in 20 patients
from od until pod5 using mHLA-DR as responder and
diabetes, BMI (dichotomized as overweight with ≤25 versus
>25 kg/m2), smoking, gender, surgical time, and age as influ-
encing factors. Smoking (𝑝 = 0.002) and gender (𝑝 = 0.026)
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Figure 2: Monocytic HLA-DR (mHLA-DR) immediately before
surgery (od) until day 5 after surgery (pod5) between smokers and
nonsmokers (error bars with 95% confidence interval). mHLA-DR
was lower in smokers on od (𝑝 = 0.010), pod4 (𝑝 = 0.098), and pod5
(𝑝 = 0.056).
were confirmed as influencing factors over time. Therefore,
smoking and gender were taken as risk factors inmultivariate
longitudinal analyses together with overweight for clinical
reasons.
3.3. Influence of Smoking on mHLA-DR. 8 out of the 20
patients were active smokers. Differences in basic patient
characteristics did not differ between smokers and nonsmok-
ers. The longitudinal analysis revealed no significant risk
factor differences (𝑝 = 0.142) but resulted in significant
changes over time (𝑝 < 0.001) and interactions (𝑝 = 0.038),
which showed increasing differences over time. In univariate
analyses, preoperative mHLA-DR was significantly lower in
smokers (𝑝 = 0.010; Figure 2) whereas a trend towards lower
levels was seen on pod4 (𝑝 = 0.098) and pod5 (𝑝 = 0.056)
in smokers. Leukocytes and CRP did not differ from od until
pod5 except for a trend towards higher CRP on pod1 (𝑝 =
0.053) in smokers. Furthermore, smokers revealed a longer
ICU stay (𝑝 = 0.047). Differences are shown in Table 1.
3.4. Influence of Overweight on mHLA-DR. Groups were
divided into normalweight (BMI≤ 25 kg/m2) and overweight
(BMI > 25 kg/m2). 12 out of 20 patients were overweight.
No differences in basic patient characteristics occurred.
The longitudinal analysis revealed no significant risk factor
differences (𝑝 = 0.079) but resulted in significant changes
over time (𝑝 < 0.001) and interactions (𝑝 = 0.011),
which showed increasing differences over time. In univariate
analyses, mHLA-DR was lower in overweight patients on
pod3 (𝑝 = 0.039) and on pod4 (𝑝 = 0.047; Figure 3).
Table 1: Basic patient characteristics and outcome parameters
between smokers and nonsmokers from od until pod5.
Smokers (𝑛 = 8) Nonsmokers
(𝑛 = 12)
𝑝 value
Age [years] 64 (56–69) 66 (55–75) 0.521
BMI [kg/m2] 25.9 (20.8–28.6) 25.4 (24.3–27.8) 0.792
Gender [m/f] 5/3 6/6 0.670
ASA score II/III [𝑛] 3/5 9/3 0.167
Diabetes in history
[no/yes] 7/1 9/3 0.619
Surgical time [min] 323 (305–405) 296 (231–367) 0.305
Periop. blood glucose
[mg/dL] 124 (120–138) 131 (119–143) 0.624
Periop. blood lactate
[mmol/L] (max.) 1.2 (0.9–1.3) 0.9 (0.8–1.1) 0.057
Periop. systolic blood
pressure [mmHg] 122 (109–137) 114 (112–116) 0.270
CRP on pod1 [mg/dL] 8.3 (7.6–9.3) 12.2 (8.3–16.9) 0.053
ICU stay [d] 5.4 (3.0–8.9) 3.5 (1.2–4.5) 0.047
Hospital stay [d] 19.0 (12.3–36.0) 15.4 (12.3–18.8) 0.384
Delirium [no/yes] 3/5 6/6 0.670
Infection [no/yes] 2/6 7/5 0.197
Leukocytes, CRP, and outcome parameters did not differ
between normal weight and overweight patients. Differences
are shown in Table 2.
3.5. Influence of Gender on mHLA-DR. 11 out of 20 patients
were male. Differences in basic patient characteristics
occurred in BMI. The longitudinal analysis revealed no
significant risk factor differences (𝑝 = 0.067) but resulted
in significant changes over time (𝑝 < 0.001). In univariate
analyses, mHLA-DR was lower in men on pod3 (𝑝 = 0.038)
and on pod5 (𝑝 = 0.026; Figure 4). Leukocytes and outcome
parameters did not differ between the groups. CRP was
higher in men on pod1 (𝑝 = 0.019). Differences are shown
in Table 3.
4. Discussion
The major finding of this subanalysis is that pre- and post-
operative mHLA-DR were influenced by smoking, gender,
and overweight. Smokers revealed an attenuated pre- and
postoperative immune function, whereas recovery ofmHLA-
DR was better in normal weight patients, women, and
nonsmokers. This is an important finding, particularly with
regard to the impact of smoking on pre- and postoperative
function on the immune system. To the best of our knowl-
edge, no other study has investigated influencing factors on
postoperative mHLA-DR up to date.
HLA-DR is a key molecule on antigen-presenting cells
and a marker of impaired immunity and immune suppres-
sion, for example, during sepsis and after surgery [1, 4, 5]. We
found lower values of mHLA-DR preoperatively in smokers
as well as higher levels of CRP and a delayed recovery
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Table 2: Basic patient characteristics and outcome parameters







Age [years] 66 (61–72) 61 (54–74) 0.384
Gender [m/f] 3/5 8/4 0.362





[no/yes] 6/2 10/2 1.000
Surgical time [min] 294 (231–388) 332 (287–383) 0.343
Periop. blood glucose
[mg/dL] 128 (119–145) 127 (120–138) 0.678
Periop. blood lactate
[mmol/L] (max.) 1.0 (0.8–1.2) 1.1 (0.8–1.2) 0.792
Periop. syst. blood
pressure [mmHg] 115 (111–123) 115 (113–119) 1.000
ICU stay [d] 4.0 (0.9–5.6) 3.9 (2.9–4.9) 0.678
Hospital stay [d] 13.5 (11.1–29.4) 16.3(13.9–22.2) 0.427
Delirium [no/yes] 4/4 5/7 1.000
Infection [no/yes] 5/3 4/8 0.362




















Figure 3: Monocytic HLA-DR (mHLA-DR) immediately before
surgery (od) until day 5 after surgery (pod5) between normal weight
and overweight patients (error bars with 95% confidence interval).
Lower levels of mHLA-DR were seen on pod3 (𝑝 = 0.039) and on
pod4 (𝑝 = 0.047) in overweight patients.
of mHLA-DR after surgery. Smoking might therefore have
direct influences on pre- and postoperative immune function,
a generally lower immunity, and delayed recovery of immune
suppression after surgery. Most likely, these alterations
Table 3: Basic patient characteristics and outcome parameters
between men and women.
Men (𝑛 = 11) Women
(𝑛 = 9)
𝑝 value







ASA score II/III [𝑛] 9/2 3/6 0.065
Diabetes in history
[no/yes] 9/2 7/2 1.000
Surgical time [min] 315 (281–385) 315 (235–394) 0.766
Periop. blood glucose
[mg/dL] 131 (123–141) 123 (110–138) 0.331
Periop. blood lactate
[mmol/L] (max.) 1.7 (1.1–2.3) 1.3 (1.1–1.7) 0.503
Periop. systolic blood
pressure [mmHg] 116 (113–123) 113 (111–118) 0.331
CRP on pod1 [mg/dL] 10.6(8.8–14.9) 7.7 (6.4–8.7) 0.019
ICU stay [d] 4.0 (2.9–4.9) 3.8 (0.9–5.3) 0.456
Hospital stay [d] 15.0(12.0–23.0)
15.9
(12.4–25.8) 1.000
Delirium [no/yes] 4/7 5/4 0.653
Infection [no/yes] 4/7 5/4 0.653




















Figure 4: Monocytic HLA-DR (mHLA-DR) immediately before
surgery (od) until day 5 after surgery (pod5) between men and
women (error bars with 95% confidence interval). mHLA-DR was
lower in men on pod3 (𝑝 = 0.038) and on pod5 (𝑝 = 0.026).
resulted in outcome differences seen in a prolonged ICU stay
in smokers. Shiels et al. found a decrease of inflammatory
markers and an increase in CRP in long-term smokers [29]
whereas Hiemstra et al. could show that inflammation is
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increased and host defence against infections is decreased by
cigarette smoke [38]. In accordance with Hiemstra et al., we
observed an increased inflammation by CRP and a decreased
host immunity by mHLA-DR. Dogan et al. conclude that
regular smoking correlates with alterations in peripheral
mononuclear cells interfering inflammatory and immune
function pathways [28]. In previous studies, smoking showed
significant interactions with subtypes of HLA-DR alleles
and therefore increased the risk of developing rheumatoid
arthritis or multiple sclerosis [30–32]. Unfortunately, our
study was not designed to analyze these interactions but
most likely smoking influences not only subtypes of HLA-
DRalleles, but alsomHLA-DRexpression.Our analyses show
that smoking is not only related to postoperative compli-
cations such as cardiovascular [39], respiratory [40], and
wound complications [41], but also related to preoperative
immunological complications that might influence or induce
postoperative complications. We hypothesize that regular
smoking has long-term effects on immunity through directly
affecting mHLA-DR. After surgery, mHLA-DR remains
impaired resulting in a delayed recovery which increases the
risk of postoperative complications [9]. Further studies are
warranted to evaluate potential pathological mechanisms.
Additionally, we found a delayed recovery of mHLA-
DR in overweight patients after surgery. Likewise diabetes,
obesity generally constitutes a chronic inflammatory state,
particularly elevated leukocyte counts, activity of granulocyte
phagocytosis and oxidative burst, and increased levels of
TNF-𝛼 and IL-6 [23, 25, 26]. Obesity is also an important
risk factor for increased mortality up to 20% and a shortened
life expectancy up to 2 to 4 years [42, 43]. In various surgical
procedures, overweight or obesity can lead to an increased
risk of postoperative infections [44–47]. We have not seen
increased CRP or leukocytes in overweight patients but an
increased risk for postoperative complications by a delayed
recovery of mHLA-DR [9]. In summary, overweight patients
had a postoperatively impaired immunity and thus most
likely an increased risk for postoperative complications.
In GEE, we found differences in postoperative mHLA-
DR between men and women over time and lower postoper-
ative levels in men in univariate analyses. Gender generally
constitutes an unmodifiable risk factor for postoperative
complications [48]. Ono et al. investigated postoperative
mHLA-DR and also found lower levels in men on day one
after gastrectomy but did not study further courses as we did
[1]. In clinical studies, male patients showed a 2 times higher
risk for postoperative infections and a 1.6 times higher rate of
pneumonia [49, 50] whereas women with nosocomial infec-
tions are at higher lethality up to 2 times [51–53]. Additionally,
women showed better outcomes after sepsis [54, 55].
Age and surgical time are also described as influencing
factors on postoperative immune function. Ono et al. found
an increased activation of monocytes and raised levels of
proinflammatory cytokines in elderly patients after surgery
[24]. Sutherland et al. demonstrated a reduced immune
response in elderly patients after surgery [56]. Surgical time
contributes also as a risk factor for postoperative infections
[57]. However, we did not see any influence of surgical time
or age on mHLA-DR.
Limitations of these analyses are first a small sample size
of 20 patients and therefore, no immune cells and cytokines
except for leukocytes and CRP were analyzed. Though sig-
nificant differences occurred, a higher sample size could
have shown more reliable results. Furthermore, we analyzed
mHLA-DR of postoperative immune suppressed patients
with a threshold level for mHLA-DR of ≤10,000mAb/cell.
Hence, the influence on mHLA-DR in less suppressed or
unsuppressed patients remains unclear.
5. Conclusion
Smokers revealed a preoperative impaired mHLA-DR
expression and a delayed recovery after surgery. Overweight
patients as well as men showed a delayed recovery of
mHLA-DR after surgery. This is an important finding,
particularly with regard to the impact of smoking on
pre- and postoperative function on the immune system.
Smoking and overweight are therefore risk factors for an
impaired immunity after surgery and an increased risk for
postoperative complications.
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